Treatment of IBS-C
Start with soluble fiber (psyllium/ispaghula) at 3-4 g/day, gradually titrating upward, and if symptoms persist after 4-6 weeks, escalate to linaclotide 290 mcg daily on an empty stomach as the preferred second-line agent. 1
First-Line Treatment: Lifestyle and Dietary Interventions
Soluble fiber is the cornerstone of initial therapy:
- Begin with psyllium or ispaghula at 3-4 g/day and build up gradually to avoid bloating and gas 1
- Optimal dosing is >10 g/day with treatment duration of at least 4 weeks for improving stool frequency and consistency 1
- Avoid insoluble fiber (wheat bran, whole grains) entirely—it consistently worsens bloating and abdominal pain in IBS-C 1
Regular physical exercise should be recommended to all IBS-C patients as foundational therapy 1
Common Pitfall to Avoid:
Do not recommend gluten-free diets unless celiac disease has been confirmed—evidence does not support their use in IBS-C 1
Second-Line Treatment: Prescription Secretagogues
When first-line therapies fail after 4-6 weeks, linaclotide is the most effective and preferred agent:
- Linaclotide 290 mcg once daily on an empty stomach (at least 30 minutes before first meal) is the gold standard second-line treatment 1, 2
- This guanylate cyclase-C agonist improves both constipation and abdominal pain 1, 2
- Diarrhea is the most common side effect but is generally manageable and occurs as the mechanism of action 1
Alternative secretagogues if linaclotide is not tolerated:
- Lubiprostone 8 mcg twice daily with food is an alternative, though it has higher rates of nausea (19% vs 14% placebo) 1, 3
- Lubiprostone is FDA-approved specifically for IBS-C in women ≥18 years old 3
- Take with food and water to reduce nausea 3
Review efficacy after 3 months and discontinue if no response 1
Third-Line Treatment: Neuromodulators for Refractory Abdominal Pain
For persistent abdominal pain despite adequate laxative therapy:
- Tricyclic antidepressants (TCAs) are the most effective option, starting with amitriptyline 10 mg once daily at bedtime 1
- Titrate slowly (by 10 mg/week) to 30-50 mg daily 1
- Critical caveat: TCAs may worsen constipation through anticholinergic effects—ensure adequate laxative therapy is in place before initiating 1
- Continue for at least 6 months if symptomatic response occurs 1
SSRIs may be effective as alternative neuromodulators when TCAs worsen constipation or are not tolerated 1
Fourth-Line Treatment: Psychological Therapies
For symptoms persisting despite 12 months of pharmacological treatment:
- IBS-specific cognitive behavioral therapy (CBT) or gut-directed hypnotherapy should be recommended 1
- These therapies have demonstrated efficacy for abdominal pain and global symptoms 1
Critical Errors to Avoid
Do NOT prescribe anticholinergic antispasmodics (dicyclomine, hyoscyamine) for IBS-C:
- These agents reduce intestinal motility and enhance water reabsorption, which will worsen the constipation 1
- This is a common error when prescribing based solely on "IBS" diagnosis without considering the constipation subtype 1
Do NOT recommend:
- IgG antibody-based food elimination diets—they lack evidence and may lead to unnecessary dietary restrictions 1
- Extensive testing once IBS-C diagnosis is established 1
Treatment Algorithm Summary
- Weeks 0-6: Soluble fiber (psyllium) 3-4 g/day gradually increased + regular exercise 1
- If inadequate response at 6 weeks: Add linaclotide 290 mcg daily on empty stomach 1, 2
- If persistent pain at 3 months: Add amitriptyline 10 mg nightly (with adequate laxative coverage) 1
- If symptoms persist at 12 months: Refer for IBS-specific CBT or gut-directed hypnotherapy 1
Review treatment efficacy every 3 months and discontinue ineffective medications 1